Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status.

ABSTRACT: The coronavirus disease (COVID-19) breakout had an unimaginable worldwide effect in the 21st century, claiming millions of lives and putting a huge burden on the global economy. The potential developments in vaccine technologies following the determination of the genetic sequence of SARS-CoV-2 and the increasing global efforts to bring potential vaccines and therapeutics into the market for emergency use have provided a small bright spot to this tragic event. Several intriguing vaccine candidates have been developed using recombinant technology, genetic engineering, and other vaccine development technologies. In the last decade, a vast amount of the vaccine development process has diversified towards the usage of viral vector-based vaccines. The immune response elicited by such vaccines is

SUBMITTER: Chavda VP 

PROVIDER: S-EPMC9965371 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature